Cell culture system could offer cancer breakthrough
A new cell culture system that provides a tool for preclinical cancer drug development and screening has been developed...
List view / Grid view
A new cell culture system that provides a tool for preclinical cancer drug development and screening has been developed...
A new biomedical tool has been developed using nanoparticles that deliver transient gene changes to targeted cells...
Researchers have developed a proof-of-concept nano-system that dramatically improves the visualisation of tumours...
Researchers have deduced how an alternative form of RNA encourages tumours to spread.
Researchers have determined that a specific region of the duodenal-jejunal flexure, shows a high frequency of gastrointestinal stromal tumours with mutations of the NF1 gene...
New research, has studied the immortalisation process using genome-engineered cells...
Scientists have synthesised a complex sugar structure that specifically binds to the tumour protein Galectin-1...
A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...
Scientists have described a new type of test that can detect genetic mutations in minute amounts of DNA...
A report published has identified the prospects of immunotherapy treatments...
A scientific collaboration has developed vascularised 3-D bioprinted liver tissue constructs, providing more precise drug toxicity testing...
US researchers have conjugated RNA to a molecule of folate, the folate receptor is overexpressed on cancer cells but very low on normal cells, which is why they can target a tumour and avoid healthy cells...
A novel chemical dubbed "T-REX," along with a patent-pending targeting molecule have uncovered interesting facets of several well-known cancer-cell mutations that, if present in a patient, could inform treatment options and potentially produce more favourable outcomes...
The move will help funded research progress toward the development of new therapeutics
Phase 2 trial to explore targeted therapies for children with solid tumours that harbour specific genetic mutations which have progressed during or after standard therapy...